Form 483

Faspac Packaging LP Form 483, 2013-04-22

FDA issued a Form 483 to Faspac Packaging LP on 2013-04-22 with 11 public-safe observations.

483· Form 483 issuedHuman Drugs11 observations

Faspac Packaging LP · Dallas, United States · Issued April 22, 2013

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Apr 2013
21 CFR 111.70(d)

Specifications - labels, packaging

Cited by Jamie M Bumpas, Elisa M Fleming

22 Apr 2013
21 CFR 111.120(e)

Quality control operations - quarantine

Cited by Jamie M Bumpas, Elisa M Fleming

22 Apr 2013
21 CFR 111.123

Quality control operations - master, batch, manufacturing

Cited by Jamie M Bumpas, Elisa M Fleming

22 Apr 2013
21 CFR 111.127

Quality control operations - packaging, labeling

Cited by Jamie M Bumpas, Elisa M Fleming

22 Apr 2013
21 CFR 111.160(d)(1)

Packaging - identify

Cited by Jamie M Bumpas, Elisa M Fleming

Inspected site

FPFaspac Packaging LPDallas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.120(e)Cited across public-safe Form 483 observations1x
21 CFR 111.123Cited across public-safe Form 483 observations1x
21 CFR 111.127Cited across public-safe Form 483 observations1x
21 CFR 111.160(d)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.70(d)Cited across public-safe Form 483 observations1x
21 CFR 211.103Cited across public-safe Form 483 observations1x
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere